| Dr Kanta Velamuri, MBBS | |
|
2002 Holcombe Blvd, Rm 3c-385, Houston, TX 77030-4211 | |
| (713) 794-7314 | |
| Not Available |
| Full Name | Dr Kanta Velamuri |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 2002 Holcombe Blvd, Houston, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598787681 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | M0596 (Texas) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | M0596 (Texas) | Primary |
| Entity Name | Baylor College Of Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881026664 PECOS PAC ID: 8022243971 Enrollment ID: O20131030000972 |
News Archive
Presidio Pharmaceuticals, Inc. today announced progress with its HCV antiviral drug discovery and development programs. A primary company objective is to advance multiple potent and safe inhibitors that target multiple HCV proteins and provide pan-genotypic coverage, as we believe such combination therapies will more adequately address the global medical need in the future.
Senate Finance Committee Chair Max Baucus (D-Mont.) on Wednesday said a Medicare package that would delay for 18 months a 10.6% cut to physician fees would cost between $15 billion and $18 billion over five years, prompting committee members to begin discussions on how to offset those costs, CQ Today reports (Wayne/Armstrong, CQ Today, 5/7).
Gilead Sciences, Inc. today announced that, in consultation with the U.S. Food and Drug Administration (FDA), the company will amend the design of ongoing clinical trials to discontinue dosing of GS 9190 in hepatitis C-infected patients who are receiving that compound in combination with pegylated interferon and ribavirin, and another direct-acting antiviral agent.
According to a new study published in the American Journal of Preventive Medicine, nearly four in ten of all youth who died by suicide in 16 states between 2009 and 2013 were Medicaid enrollees.
NetLearning, part of Cengage Learning and a leading provider of online courses and eLearning software for healthcare workers and hospital administrators, today announced an expanded relationship with the American Heart Association (AHA), the leader in emergency cardiovascular care resources, to distribute additional course offerings.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kanta Velamuri, MBBS 2203 Delta Bridge Court, Pearland, TX 77584 Ph: (713) 436-9697 | Dr Kanta Velamuri, MBBS 2002 Holcombe Blvd, Rm 3c-385, Houston, TX 77030-4211 Ph: (713) 794-7314 |
News Archive
Presidio Pharmaceuticals, Inc. today announced progress with its HCV antiviral drug discovery and development programs. A primary company objective is to advance multiple potent and safe inhibitors that target multiple HCV proteins and provide pan-genotypic coverage, as we believe such combination therapies will more adequately address the global medical need in the future.
Senate Finance Committee Chair Max Baucus (D-Mont.) on Wednesday said a Medicare package that would delay for 18 months a 10.6% cut to physician fees would cost between $15 billion and $18 billion over five years, prompting committee members to begin discussions on how to offset those costs, CQ Today reports (Wayne/Armstrong, CQ Today, 5/7).
Gilead Sciences, Inc. today announced that, in consultation with the U.S. Food and Drug Administration (FDA), the company will amend the design of ongoing clinical trials to discontinue dosing of GS 9190 in hepatitis C-infected patients who are receiving that compound in combination with pegylated interferon and ribavirin, and another direct-acting antiviral agent.
According to a new study published in the American Journal of Preventive Medicine, nearly four in ten of all youth who died by suicide in 16 states between 2009 and 2013 were Medicaid enrollees.
NetLearning, part of Cengage Learning and a leading provider of online courses and eLearning software for healthcare workers and hospital administrators, today announced an expanded relationship with the American Heart Association (AHA), the leader in emergency cardiovascular care resources, to distribute additional course offerings.
› Verified 9 days ago
Dr. Michaela Elizabeth Ginn, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 13214 Indian Creek Road, Houston, TX 77079 Phone: 713-591-3555 Fax: 661-321-3286 | |
Ameena Bagree Malhotra, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1515 Holcombe Blvd, 77030-4009, Houston, TX 77030 Phone: 713-792-6161 | |
Svetang Vijay Desai, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 444 Fm 1959 Rd, Suite A, Houston, TX 77034 Phone: 281-481-9400 | |
Dr. Stalin R Subramanian, M.D Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 7200 Cambridge St Fl 8, Houston, TX 77030 Phone: 713-798-0950 | |
Robin Boliver-campbell, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 7141 Southwest Fwy, Houston, TX 77074 Phone: 713-771-7921 Fax: 713-264-8659 | |
Henna Mukhtar Malik, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 13215 Dotson Rd Ste 300, Houston, TX 77070 Phone: 281-894-8822 | |
Zaven Sargsyan, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1504 Taub Loop, Houston, TX 77030 Phone: 713-873-8890 |